Search Results

A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity

Authors: Lehenbauer Ludke, Ana R.; Al-Shudiefat, Abd A.l-R.a.h.m.a.n.S.; Dhingra, Sanjiv; Jassal, Davinder S.; Singal, Pawan K.

Source: Canadian Journal of Physiology and Pharmacology, Volume 87, Number 10, 1 October 2009 , pp. 756-763(8)

Publisher: NRC Research Press

Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity

Authors: Demirkaya, Erkan; Avci, Aslıhan; Kesik, Vural; Karslioglu, Yıldırım; Oztas, Emin; Kismet, Erol; Gokcay, Erdal; Durak, Ilker; Koseoglu, Vedat

Source: Canadian Journal of Physiology and Pharmacology, Volume 87, Number 8, 1 August 2009 , pp. 633-640(8)

Publisher: NRC Research Press

Les toxicités cardiovasculaires des traitements oncologiques

Authors: Kalou, K.; Zelek, L.

Source: Oncologie, Volume 8, Number 10, December 2006 , pp. 901-905(5)

Publisher: Springer

La cardiotoxicité des anthracyclines : mécanismes et cibles pharmacologiques de prévention: Molecular Mechanisms of Anthracycline-Induced Cardiotoxicity and its Prevention

Author: Nathalie Andrieu-Abadie

Source: Therapie, Volume 59, Number 1, 2004 , pp. 121-126(6)

Publisher: Adis International

Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

Authors: Woodland C.; Koren G.; Wainer I.W.; Batist G.; Ito S.

Source: Canadian Journal of Physiology and Pharmacology, Volume 81, Number 8, 1 August 2003 , pp. 800-805(6)

Publisher: NRC Research Press

Cardiotoxicité du 5-fluorouracil: à propos de 6 nouveaux cas

Authors: Timour Q.; Lombard-Bohas C.; Slim R.; Barel C.; Bui-Xuan B.; Tabib A.; Bricca G.; Malonne H.; Vial1 T.; Iordescu D.; Descotes J.

Source: Therapie, Volume 57, Number 3, 2002 , pp. 302-306(5)

Publisher: Adis International

The cardiovascular effects associated with the use of the chloroquinine

Authors: Queyriaux B.; Carlioz R.; Perrier E.; Micaelli P.; Gressard A.; Deroche J.; Leduc P.A.; Quiniou G.; Burlaton J.P.

Source: Annales de Cardiologie et d'Angeiologie, Volume 50, Number 5, September 2001 , pp. 285-292(8)

Publisher: Elsevier

Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice

Authors: Saadane N.; Yue P.; Alpert L.; Mitmaker B.; Kirby G.M.; Chalifour L.E.

Source: Canadian Journal of Physiology and Pharmacology, Volume 79, Number 6, June 2001 , pp. 533-544(12)

Publisher: NRC Research Press

Emergency coronary angioplasty following treatment with 5-fluorouracil

Authors: Prunier F.; Monsegu J.; Coutant G.; Ollivier J.P.

Source: La Revue de Medecine Interne, Volume 21, Number 5, May 2000 , pp. 439-444(6)

Publisher: Elsevier

Complete heart block in long-term choroquine therapy

Authors: Duvic C.; Pats B.; Rouvier B.

Source: La Revue de Medecine Interne, Volume 21, Number 5, May 2000 , pp. 462-463(2)

Publisher: Elsevier

Cardiotoxic effects of acute citalopram overdose

Authors: Fromajoux A.; Saviuc P.; Danel V.; Vincent F.

Source: Reanimation Urgences, Volume 7, Number 5, October 1998 , pp. 585-588(4)

Publisher: Elsevier

Malaise with long QT interval in a 39-day old infant during cisapride treatment

Authors: Valdes L.; Champel V.; Olivier C.; Jonville-Bera A.; Autret E.

Source: Archives de Pediatrie, Volume 4, Number 6, June 1997 , pp. 535-537(3)

Publisher: Elsevier

Modification du signal ECG moyenne en cas de toxicite myocardique aux anthracyclines chez l'enfant

Authors: Vaksmann G.; Francart C.; Nelken B.; Duhamel A.; Godard F.; Rey C.

Source: Archives de Pediatrie, Volume 3, Number 7, July 1996 , pp. 733-733(1)

Publisher: Elsevier

Maladie de hodgkin de l'enfant st'ade I et II: resultants preliminaires de l'etude MDH 90 menee par la societe francaise d'oncologie pediatrique (SFOP)

Authors: Landman-Parker J.; Oberlin O.; Leverger G.

Source: Archives de Pediatrie, Volume 3, Supplement 1, 1 May 1996 , pp. 371s-371s(1)

Publisher: Elsevier